Gut microbiota and their neuroinflammatory implications in alzheimer’s disease

Nutrients

Volumn 10, Issue 11, 2018, Pages

  Van Giau, Vo ^a   Wu, Si Ying ^a   Jamerlan, Angelo ^a   An, Seong Soo A ^a   Kim, Sang Yun ^b   Hulme, John ^a  

^a Gachon University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

Author keywords

Alzheimer s disease; Germ free animal; Gut microbiota; MGB axis; Neurodegenerative diseases; Probiotic

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIBIOTIC AGENT; CYTOKINE; DOPAMINE; ENDOTOXIN; HISTAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NEUROTRANSMITTER; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ALZHEIMER DISEASE; ASTROCYTE; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENDOTOXEMIA; ESCHERICHIA; GASTROINTESTINAL TRACT; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE SYSTEM; INFLAMMATION; INTESTINE FLORA; INTESTINE INNERVATION; LACTOBACILLUS; LANGUAGE DISABILITY; MEMORY DISORDER; MENTAL DISEASE; MICROBIAL COLONIZATION; MICROGLIA; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROENDOCRINE SYSTEM; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STREPTOCOCCUS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; HUMANS; INFLAMMATION;

EID: 85056627716     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu10111765     Document Type: Review

References (140)

1. Fung, T.C.; Olson, C.A.; Hsiao, E.Y. Interactions between the microbiota, immune and nervous systems in health and disease. Nat. Neurosci. 2017, 20, 145–155. [CrossRef] [PubMed]
2. Sender, R.; Fuchs, S.; Milo, R. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans. Cell 2016, 164, 337–340. [CrossRef] [PubMed]
3. Qin, J.; Li, R.; Raes, J.; Arumugam, M.; Burgdorf, K.S.; Manichanh, C.; Nielsen, T.; Pons, N.; Levenez, F.; Yamada, T.; et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65. [CrossRef] [PubMed]
4. Villaran, R.F.; Espinosa-Oliva, A.M.; Sarmiento, M.; De Pablos, R.M.; Arguelles, S.; Delgado-Cortes, M.J.; Sobrino, V.; Van Rooijen, N.; Venero, J.L.; Herrera, A.J.; et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: Potential risk factor in Parkinson’s disease. J. Neurochem. 2010, 114, 1687–1700. [CrossRef] [PubMed]
5. O’Hara, A.M.; Shanahan, F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7, 688–693. [CrossRef] [PubMed]
6. Morais, G.C.P.; Arruda, M.M.; Bonadia, J.C.A.; Pozzan, G. Cardiac amyloidosis: A challenging diagnosis. Autops. Case Rep. 2014, 4, 9–17. [CrossRef] [PubMed]
7. Sperry, B.W.; Tang, W.H.W. Amyloid heart disease: Genetics translated into disease-modifying therapy. Heart 2017, 103, 812–817. [CrossRef] [PubMed]
8. Rogers, G.B.; Keating, D.J.; Young, R.L.; Wong, M.L.; Licinio, J.; Wesselingh, S. From gut dysbiosis to altered brain function and mental illness: Mechanisms and pathways. Mol. Psychiatry 2016, 21, 738–748. [CrossRef] [PubMed]
9. Bostanciklioğlu, M. Intestinal Bacterial Flora and Alzheimer’s Disease. Neurophysiology 2018, 50, 140–148. [CrossRef]
10. Morris, G.; Berk, M.; Maes, M.; Puri, B.K. Could Alzheimer’s Disease Originate in the Periphery and If So How So? Mol. Neurobiol. 2018. [CrossRef] [PubMed]
11. Lukiw, W.J.; Bazan, N.G. Survival signalling in Alzheimer’s disease. Biochem. Soc. Trans. 2006, 34 Pt 6, 1277–1282. [CrossRef]
12. Bagyinszky, E.; Giau, V.V.; Shim, K.; Suk, K.; An, S.S.A.; Kim, S. Role of inflammatory molecules in the Alzheimer’s disease progression and diagnosis. J. Neurol. Sci. 2017, 376, 242–254. [CrossRef] [PubMed]
13. Cammarota, G.; Ianiro, G.; Bibbo, S.; Gasbarrini, A. Gut microbiota modulation: Probiotics, antibiotics or fecal microbiota transplantation? Intern. Emerg. Med. 2014, 9, 365–373. [CrossRef] [PubMed]
14. Schmidt, T.S.B.; Raes, J.; Bork, P. The Human Gut Microbiome: From Association to Modulation. Cell 2018, 172, 1198–1215. [CrossRef] [PubMed]
15. Cox, L.M.; Weiner, H.L. Microbiota Signaling Pathways that Influence Neurologic Disease. Neurotherapeutics 2018, 15, 135–145. [CrossRef] [PubMed]
16. O’Toole, P.W.; Jeffery, I.B. Microbiome-health interactions in older people. Cell. Mol. Life Sci. CMLS 2018, 75, 119–128. [CrossRef] [PubMed]
17. Nicholson, J.K.; Holmes, E.; Kinross, J.; Burcelin, R.; Gibson, G.; Jia, W.; Pettersson, S. Host-gut microbiota metabolic interactions. Science 2012, 336, 1262–1267. [CrossRef] [PubMed]
18. Yatsunenko, T.; Rey, F.E.; Manary, M.J.; Trehan, I.; Dominguez-Bello, M.G.; Contreras, M.; Magris, M.; Hidalgo, G.; Baldassano, R.N.; Anokhin, A.P.; et al. Human gut microbiome viewed across age and geography. Nature 2012, 486, 222–227. [CrossRef] [PubMed]
19. Arimatsu, K.; Yamada, H.; Miyazawa, H.; Minagawa, T.; Nakajima, M.; Ryder, M.I.; Gotoh, K.; Motooka, D.; Nakamura, S.; Iida, T.; et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci. Rep. 2014, 4, 4828. [CrossRef] [PubMed]
20. Ding, Y.; Ren, J.; Yu, H.; Yu, W.; Zhou, Y. Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun. Ageing 2018, 15, 6. [CrossRef] [PubMed]
21. Briguglio, M.; Dell’Osso, B.; Panzica, G.; Malgaroli, A.; Banfi, G.; Zanaboni Dina, C.; Galentino, R.; Porta, M. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients 2018, 10, 591. [CrossRef] [PubMed]
22. Lyte, M.; Villageliú, D.N.; Crooker, B.A.; Brown, D.R. Symposium review: Microbial endocrinology—Why the integration of microbes, epithelial cells, and neurochemical signals in the digestive tract matters to ruminant health1. J. Dairy Sci. 2018, 101, 5619–5628. [CrossRef] [PubMed]
23. Thomas, C.M.; Hong, T.; van Pijkeren, J.P.; Hemarajata, P.; Trinh, D.V.; Hu, W.; Britton, R.A.; Kalkum, M.; Versalovic, J. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS ONE 2012, 7, e31951. [CrossRef] [PubMed]
24. Wall, R.; Cryan, J.F.; Ross, R.P.; Fitzgerald, G.F.; Dinan, T.G.; Stanton, C. Bacterial neuroactive compounds produced by psychobiotics. Adv. Exp. Med. Biol. 2014, 817, 221–239. [PubMed]
25. Kau, A.L.; Ahern, P.P.; Griffin, N.W.; Goodman, A.L.; Gordon, J.I. Human nutrition, the gut microbiome, and immune system: Envisioning the future. Nature 2011, 474, 327–336. [CrossRef] [PubMed]
26. Fukudo, S. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation. J. Gastroenterol. 2007, 42 (Suppl. 17), 48–51. [CrossRef]
27. Nishino, R.; Mikami, K.; Takahashi, H.; Tomonaga, S.; Furuse, M.; Hiramoto, T.; Aiba, Y.; Koga, Y.; Sudo, N. Commensal microbiota modulate murine behaviors in a strictly contamination-free environment confirmed by culture-based methods. Neurogastroenterol. Motil. 2013, 25, 521–528. [CrossRef] [PubMed]
28. Hooper, L.V.; Littman, D.R.; Macpherson, A.J. Interactions between the microbiota and the immune system. Science 2012, 336, 1268–1273. [CrossRef] [PubMed]
29. Holmes, E.; Kinross, J.; Gibson, G.R.; Burcelin, R.; Jia, W.; Pettersson, S.; Nicholson, J.K. Therapeutic modulation of microbiota-host metabolic interactions. Sci. Transl. Med. 2012, 4, 137rv6. [CrossRef] [PubMed]
30. Santilli, A.D.; Dawson, E.M.; Whitehead, K.J.; Whitehead, D.C. Nonmicrobicidal Small Molecule Inhibition of Polysaccharide Metabolism in Human Gut Microbes: A Potential Therapeutic Avenue. ACS Chem. Biol. 2018, 13, 1165–1172. [CrossRef] [PubMed]
31. Forsythe, P.; Bienenstock, J. Immunomodulation by commensal and probiotic bacteria. Immunol. Investig. 2010, 39, 429–448. [CrossRef] [PubMed]
32. Bercik, P.; Park, A.J.; Sinclair, D.; Khoshdel, A.; Lu, J.; Huang, X.; Deng, Y.; Blennerhassett, P.A.; Fahnestock, M.; Moine, D.; et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol. Motil. 2011, 23, 1132–1139. [CrossRef] [PubMed]
33. Halfvarson, J.; Brislawn, C.J.; Lamendella, R.; Vazquez-Baeza, Y.; Walters, W.A.; Bramer, L.M.; D’Amato, M.; Bonfiglio, F.; McDonald, D.; Gonzalez, A.; et al. Dynamics of the human gut microbiome in inflammatory bowel disease. Nat. Microbiol. 2017, 2, 17004. [CrossRef] [PubMed]
34. Moser, G.; Fournier, C.; Peter, J. Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wiener Medizinische Wochenschrift 2018, 168, 62–66. [CrossRef] [PubMed]
35. Atamna, A.; Elis, A.; Gilady, E.; Gitter-Azulay, L.; Bishara, J. How obesity impacts outcomes of infectious diseases. Eur. J. Clin. Microbiol. Infect. Dis. 2017, 36, 585–591. [CrossRef] [PubMed]
36. Le Roy, C.I.; Beaumont, M.; Jackson, M.A.; Steves, C.J.; Spector, T.D.; Bell, J.T. Heritable components of the human fecal microbiome are associated with visceral fat. Gut microbes 2018, 9, 61–67. [CrossRef] [PubMed]
37. Mennini, M.; Dahdah, L.; Artesani, M.C.; Fiocchi, A.; Martelli, A. Probiotics in Asthma and Allergy Prevention. Front. Pediatr. 2017, 5, 165. [CrossRef] [PubMed]
38. Mulders, R.J.; de Git, K.C.G.; Schele, E.; Dickson, S.L.; Sanz, Y.; Adan, R.A.H. Microbiota in obesity: Interactions with enteroendocrine, immune and central nervous systems. Obes. Rev. 2018, 19, 435–451. [CrossRef] [PubMed]
39. Stilling, R.M.; Dinan, T.G.; Cryan, J.F. Microbial genes, brain & behavior—Epigenetic regulation of the gut-brain axis. Genes Brain Behav. 2014, 13, 69–86. [PubMed]
40. Dinan, T.G.; Cryan, J.F. Gut instincts: Microbiota as a key regulator of brain development, ageing and neurodegeneration. J. Physiol. 2017, 595, 489–503. [CrossRef] [PubMed]
41. Kohler, C.A.; Maes, M.; Slyepchenko, A.; Berk, M.; Solmi, M.; Lanctot, K.L.; Carvalho, A.F. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer’s Disease. Curr. Pharm. Des. 2016, 22, 6152–6166. [CrossRef] [PubMed]
42. Cussotto, S.; Sandhu, K.V.; Dinan, T.G.; Cryan, J.F. The Neuroendocrinology of the Microbiota-Gut-Brain Axis: A Behavioural Perspective. Front. Neuroendocrinol. 2018, 51, 80–101. [CrossRef] [PubMed]
43. Münger, E.; Montiel-Castro, A.J.; Langhans, W.; Pacheco-López, G. Reciprocal Interactions Between Gut Microbiota and Host Social Behavior. Front. Integr. Neurosci. 2018, 12, 21. [CrossRef] [PubMed]
44. Cowan, C.S.M.; Hoban, A.E.; Ventura-Silva, A.P.; Dinan, T.G.; Clarke, G.; Cryan, J.F. Gutsy Moves: The Amygdala as a Critical Node in Microbiota to Brain Signaling. BioEssays 2018, 40. [CrossRef] [PubMed]
45. Bravo, J.A.; Forsythe, P.; Chew, M.V.; Escaravage, E.; Savignac, H.M.; Dinan, T.G.; Bienenstock, J.; Cryan, J.F. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. USA 2011, 108, 16050–16055. [CrossRef] [PubMed]
46. Distrutti, E.; Monaldi, L.; Ricci, P.; Fiorucci, S. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World J. Gastroenterol. 2016, 22, 2219–2241. [CrossRef] [PubMed]
47. Hestad, K.A.; Engedal, K.; Whist, J.E.; Farup, P.G. The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance. Front. Psychol. 2017, 8, 1561. [CrossRef] [PubMed]
48. Tillisch, K.; Labus, J.; Kilpatrick, L.; Jiang, Z.; Stains, J.; Ebrat, B.; Guyonnet, D.; Legrain-Raspaud, S.; Trotin, B.; Naliboff, B.; et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144, 1394–1401. [CrossRef] [PubMed]
49. De Palma, G.; Collins, S.M.; Bercik, P. The microbiota-gut-brain axis in functional gastrointestinal disorders. Gut Microbes 2014, 5, 419–429. [CrossRef] [PubMed]
50. Backhed, F. Programming of host metabolism by the gut microbiota. Ann. Nutr. Metab. 2011, 58 (Suppl. 2), 44–52. [CrossRef]
51. Luczynski, P.; McVey Neufeld, K.A.; Oriach, C.S.; Clarke, G.; Dinan, T.G.; Cryan, J.F. Growing up in a Bubble: Using Germ-Free Animals to Assess the Influence of the Gut Microbiota on Brain and Behavior. Int. J. Neuropsychopharmacol. 2016, 19. [CrossRef] [PubMed]
52. Hansen, C.H.; Nielsen, D.S.; Kverka, M.; Zakostelska, Z.; Klimesova, K.; Hudcovic, T.; Tlaskalova-Hogenova, H.; Hansen, A.K. Patterns of early gut colonization shape future immune responses of the host. PLoS ONE 2012, 7, e34043. [CrossRef] [PubMed]
53. Olszak, T.; An, D.; Zeissig, S.; Vera, M.P.; Richter, J.; Franke, A.; Glickman, J.N.; Siebert, R.; Baron, R.M.; Kasper, D.L.; et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336, 489–493. [CrossRef] [PubMed]
54. Pabst, O.; Cerovic, V.; Hornef, M. Secretory IgA in the Coordination of Establishment and Maintenance of the Microbiota. Trends Immunol. 2016, 37, 287–296. [CrossRef] [PubMed]
55. McCoy, K.D.; Ronchi, F.; Geuking, M.B. Host-microbiota interactions and adaptive immunity. Immunol. Rev. 2017, 279, 63–69. [CrossRef] [PubMed]
56. Macpherson, A.J.; Geuking, M.B.; McCoy, K.D. Homeland security: IgA immunity at the frontiers of the body. Trends Immunol. 2012, 33, 160–167. [CrossRef] [PubMed]
57. Girolamo, F.; Coppola, C.; Ribatti, D. Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases. Brain Behav. Immun. 2017, 65, 68–89. [CrossRef] [PubMed]
58. Lyte, M.; Li, W.; Opitz, N.; Gaykema, R.P.; Goehler, L.E. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 2006, 89, 350–357. [CrossRef] [PubMed]
59. Hoban, A.E.; Stilling, R.M.; Moloney, G.; Shanahan, F.; Dinan, T.G.; Clarke, G.; Cryan, J.F. The microbiome regulates amygdala-dependent fear recall. Mol. Psychiatry 2018, 23, 1134–1144. [CrossRef] [PubMed]
60. Bercik, P.; Verdu, E.F.; Foster, J.A.; Macri, J.; Potter, M.; Huang, X.; Malinowski, P.; Jackson, W.; Blennerhassett, P.; Neufeld, K.A.; et al. Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology 2010, 139, 2102–2112. [CrossRef] [PubMed]
61. He, B.; Hoang, T.K.; Wang, T.; Ferris, M.; Taylor, C.M.; Tian, X.; Luo, M.; Tran, D.Q.; Zhou, J.; Tatevian, N.; et al. Resetting microbiota by Lactobacillus reuteri inhibits T reg deficiency-induced autoimmunity via adenosine A2A receptors. J. Exp. Med. 2017, 214, 107–123. [CrossRef] [PubMed]
62. O’Shea, E.F.; Cotter, P.D.; Stanton, C.; Ross, R.P.; Hill, C. Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: Bacteriocins and conjugated linoleic acid. Int. J. Food Microbiol. 2012, 152, 189–205. [CrossRef] [PubMed]
63. Grant, M.C.; Baker, J.S. An overview of the effect of probiotics and exercise on mood and associated health conditions. Crit. Rev. Food Sci. Nutr. 2017, 57, 3887–3893. [CrossRef] [PubMed]
64. Ventura, M.; O’Flaherty, S.; Claesson, M.J.; Turroni, F.; Klaenhammer, T.R.; van Sinderen, D.; O’Toole, P.W. Genome-scale analyses of health-promoting bacteria: Probiogenomics. Nat. Rev. Microbiol. 2009, 7, 61–71. [CrossRef] [PubMed]
65. Vanhaecke, T.; Aubert, P.; Grohard, P.A.; Durand, T.; Hulin, P.; Paul-Gilloteaux, P.; Fournier, A.; Docagne, F.; Ligneul, A.; Fressange-Mazda, C.; et al. L. fermentum CECT 5716 prevents stress-induced intestinal barrier dysfunction in newborn rats. Neurogastroenterol. Motil. 2017, 29, e13069. [CrossRef] [PubMed]
66. Ladirat, S.E.; Schoterman, M.H.; Rahaoui, H.; Mars, M.; Schuren, F.H.; Gruppen, H.; Nauta, A.; Schols, H.A. Exploring the effects of galacto-oligosaccharides on the gut microbiota of healthy adults receiving amoxicillin treatment. Br. J. Nutr. 2014, 112, 536–546. [CrossRef] [PubMed]
67. Tulstrup, M.V.-L.; Christensen, E.G.; Carvalho, V.; Linninge, C.; Ahrné, S.; Højberg, O.; Licht, T.R.; Bahl, M.I. Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class. PLoS ONE 2015, 10, e0144854. [CrossRef] [PubMed]
68. Vrieze, A.; Out, C.; Fuentes, S.; Jonker, L.; Reuling, I.; Kootte, R.S.; van Nood, E.; Holleman, F.; Knaapen, M.; Romijn, J.A.; et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J. Hepatol. 2014, 60, 824–831. [CrossRef] [PubMed]
69. Candon, S.; Perez-Arroyo, A.; Marquet, C.; Valette, F.; Foray, A.P.; Pelletier, B.; Milani, C.; Ventura, M.; Bach, J.F.; Chatenoud, L. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS ONE 2015, 10, e0125448. [CrossRef] [PubMed]
70. Rodrigues, R.R.; Greer, R.L.; Dong, X.; KN, D.S.; Gurung, M.; Wu, J.Y.; Morgun, A.; Shulzhenko, N. Antibiotic-Induced Alterations in Gut Microbiota Are Associated with Changes in Glucose Metabolism in Healthy Mice. Front. Microbiol. 2017, 8, 2306. [CrossRef] [PubMed]
71. Fouhy, F.; Guinane, C.M.; Hussey, S.; Wall, R.; Ryan, C.A.; Dempsey, E.M.; Murphy, B.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C.; et al. High-throughput sequencing reveals the incomplete, short-term recovery of infant gut microbiota following parenteral antibiotic treatment with ampicillin and gentamicin. Antimicrob. Agents Chemother. 2012, 56, 5811–5820. [CrossRef] [PubMed]
72. Tanaka, S.; Kobayashi, T.; Songjinda, P.; Tateyama, A.; Tsubouchi, M.; Kiyohara, C.; Shirakawa, T.; Sonomoto, K.; Nakayama, J. Influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota. FEMS Immunol. Med. Microbiol. 2009, 56, 80–87. [CrossRef] [PubMed]
73. Jernberg, C.; Lofmark, S.; Edlund, C.; Jansson, J.K. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J. 2007, 1, 56–66. [CrossRef] [PubMed]
74. Panda, S.; El khader, I.; Casellas, F.; Lopez Vivancos, J.; Garcia Cors, M.; Santiago, A.; Cuenca, S.; Guarner, F.; Manichanh, C. Short-term effect of antibiotics on human gut microbiota. PLoS ONE 2014, 9, e95476. [CrossRef] [PubMed]
75. Jakobsson, H.E.; Jernberg, C.; Andersson, A.F.; Sjolund-Karlsson, M.; Jansson, J.K.; Engstrand, L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS ONE 2010, 5, e9836. [CrossRef] [PubMed]
76. Rieder, R.; Wisniewski, P.J.; Alderman, B.L.; Campbell, S.C. Microbes and mental health: A review. Brain Behave. Immunity 2017, 66, 9–17. [CrossRef] [PubMed]
77. Albenberg, L.G.; Wu, G.D. Diet and the intestinal microbiome: Associations, functions, and implications for health and disease. Gastroenterology 2014, 146, 1564–1572. [CrossRef] [PubMed]
78. Asti, A.; Gioglio, L. Can a bacterial endotoxin be a key factor in the kinetics of amyloid fibril formation? J. Alzheimer’s Dis. JAD 2014, 39, 169–179. [CrossRef] [PubMed]
79. Collins, S.M.; Surette, M.; Bercik, P. The interplay between the intestinal microbiota and the brain. Nat. Rev. Microbiol. 2012, 10, 735–742. [CrossRef] [PubMed]
80. Hanstock, T.L.; Mallet, P.E.; Clayton, E.H. Increased plasma d-lactic acid associated with impaired memory in rats. Physiol. Behav. 2010, 101, 653–659. [CrossRef] [PubMed]
81. De Haas, E.N.; van der Eijk, J.A.J. Where in the serotonergic system does it go wrong? Unravelling the route by which the serotonergic system affects feather pecking in chickens. Neurosci. Biobehav. Rev. 2018, 95, 170–188. [CrossRef] [PubMed]
82. Hernandez-Rapp, J.; Martin-Lannerée, S.; Hirsch, T.Z.; Launay, J.-M.; Mouillet-Richard, S. Hijacking PrP(c)-dependent signal transduction: When prions impair Aβ clearance. Front. Aging Neurosci. 2014, 6, 25. [CrossRef] [PubMed]
83. Daulatzai, M.A. Chronic functional bowel syndrome enhances gut-brain axis dysfunction, neuroinflammation, cognitive impairment, and vulnerability to dementia. Neurochem. Res. 2014, 39, 624–644. [CrossRef] [PubMed]
84. Johnson, K.V.; Foster, K.R. Why does the microbiome affect behaviour? Nat. Rev. Microbiol. 2018, 16, 647–655. [CrossRef] [PubMed]
85. Rhee, S.H.; Pothoulakis, C.; Mayer, E.A. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat. Rev. Gastroenterol. Hepatol. 2009, 6, 306–314. [CrossRef] [PubMed]
86. Tsavkelova, E.A.; Botvinko, I.V.; Kudrin, V.S.; Oleskin, A.V. Detection of neurotransmitter amines in microorganisms with the use of high-performance liquid chromatography. Dokl. Biochem. 2000, 372, 115–117. [PubMed]
87. Shishov, V.A.; Kirovskaia, T.A.; Kudrin, V.S.; Oleskin, A.V. (Amine neuromediators, their precursors, and oxidation products in the culture of Escherichia coli K-12). Prikladnaia Biokhimiia i Mikrobiologiia 2009, 45, 550–554. [CrossRef] [PubMed]
88. Özogul, F. Effects of specific lactic acid bacteria species on biogenic amine production by foodborne pathogen. Int. J. Food Sci. Technol. 2011, 46, 478–484. [CrossRef]
89. Kawashima, K.; Misawa, H.; Moriwaki, Y.; Fujii, Y.X.; Fujii, T.; Horiuchi, Y.; Yamada, T.; Imanaka, T.; Kamekura, M. Ubiquitous expression of acetylcholine and its biological functions in life forms without nervous systems. Life Sci. 2007, 80, 2206–2209. [CrossRef] [PubMed]
90. Landete, J.M.; De las Rivas, B.; Marcobal, A.; Munoz, R. Updated molecular knowledge about histamine biosynthesis by bacteria. Crit. Rev. Food Sci. Nutr. 2008, 48, 697–714. [CrossRef] [PubMed]
91. Rothhammer, V.; Borucki, D.M.; Tjon, E.C.; Takenaka, M.C.; Chao, C.-C.; Ardura-Fabregat, A.; de Lima, K.A.; Gutiérrez-Vázquez, C.; Hewson, P.; Staszewski, O.; et al. Microglial control of astrocytes in response to microbial metabolites. Nature 2018, 557, 724–728. [CrossRef] [PubMed]
92. Wekerle, H. Brain inflammatory cascade controlled by gut-derived molecules. Nature 2018, 557, 642–643. [CrossRef] [PubMed]
93. Cho, H.S.; Lee, J.H.; Ryu, S.Y.; Joo, S.W.; Cho, M.H.; Lee, J. Inhibition of Pseudomonas aeruginosa and Escherichia coli O157:H7 biofilm formation by plant metabolite epsilon-viniferin. J. Agric. Food Chem. 2013, 61, 7120–7126. [CrossRef] [PubMed]
94. Gao, J.; Xu, K.; Liu, H.; Liu, G.; Bai, M.; Peng, C.; Li, T.; Yin, Y. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Front. Cell. Infect. Microbiol. 2018, 8, 13. [CrossRef] [PubMed]
95. Wynendaele, E.; Verbeke, F.; Stalmans, S.; Gevaert, B.; Janssens, Y.; Van De Wiele, C.; Peremans, K.; Burvenich, C.; De Spiegeleer, B. Quorum Sensing Peptides Selectively Penetrate the Blood-Brain Barrier. PLoS ONE 2015, 10, e0142071. [CrossRef] [PubMed]
96. Schluter, J.; Schoech, A.P.; Foster, K.R.; Mitri, S. The Evolution of Quorum Sensing as a Mechanism to Infer Kinship. PLoS Comput. Biol. 2016, 12, e1004848. [CrossRef] [PubMed]
97. Levi, M.; Keller, T.T.; van Gorp, E.; ten Cate, H. Infection and inflammation and the coagulation system. Cardiovasc. Res. 2003, 60, 26–39. [CrossRef]
98. Harach, T.; Marungruang, N.; Duthilleul, N.; Cheatham, V.; Mc Coy, K.D.; Frisoni, G.; Neher, J.J.; Fåk, F.; Jucker, M.; Lasser, T.; et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Sci. Rep. 2017, 7, 41802. [CrossRef] [PubMed]
99. Feng, Q.; Chen, W.-D.; Wang, Y.-D. Gut Microbiota: An Integral Moderator in Health and Disease. Front. Microbiol. 2018, 9, 151. [CrossRef] [PubMed]
100. Hill, J.M.; Lukiw, W.J. Microbial-generated amyloids and Alzheimer’s disease (AD). Front. Aging Neurosci. 2015, 7, 9. [CrossRef] [PubMed]
101. Roubaud-Baudron, C.; Krolak-Salmon, P.; Quadrio, I.; Megraud, F.; Salles, N. Impact of chronic Helicobacter pylori infection on Alzheimer’s disease: Preliminary results. Neurobiol. Aging 2012, 33, 1009.e11–1019.e19. [CrossRef] [PubMed]
102. Gerard, H.C.; Dreses-Werringloer, U.; Wildt, K.S.; Deka, S.; Oszust, C.; Balin, B.J.; Frey, W.H., 2nd; Bordayo, E.Z.; Whittum-Hudson, J.A.; Hudson, A.P. Chlamydophila (Chlamydia) pneumoniae in the Alzheimer’s brain. FEMS Immunol. Med. Microbiol. 2006, 48, 355–366. [CrossRef] [PubMed]
103. Kountouras, J.; Gavalas, E.; Zavos, C.; Stergiopoulos, C.; Chatzopoulos, D.; Kapetanakis, N.; Gisakis, D. Alzheimer’s disease and Helicobacter pylori infection: Defective immune regulation and apoptosis as proposed common links. Med. Hypotheses 2007, 68, 378–388. [CrossRef] [PubMed]
104. Prandota, J. Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am. J. Alzheimer’s Dis. Dement. 2014, 29, 205–214. [CrossRef] [PubMed]
105. Ball, M.J. Limbic predilection in Alzheimer dementia: Is reactivated herpesvirus involved? Can. J. Neurol. Sci. Le J. Can. Sci. Neurol. 1982, 9, 303–306. [CrossRef]
106. Lurain, N.S.; Hanson, B.A.; Martinson, J.; Leurgans, S.E.; Landay, A.L.; Bennett, D.A.; Schneider, J.A. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J. Infect. Dis. 2013, 208, 564–572. [CrossRef] [PubMed]
107. Chiu, W.C.; Tsan, Y.T.; Tsai, S.L.; Chang, C.J.; Wang, J.D.; Chen, P.C. Hepatitis C viral infection and the risk of dementia. Eur. J. Neurol. 2014, 21, 1068-59. [CrossRef] [PubMed]
108. Kong, Y.; Jiang, B.; Luo, X. Gut microbiota influences Alzheimer’s disease pathogenesis by regulating acetate in Drosophila model. Future Microbiol. 2018, 13, 1117–1128. [CrossRef] [PubMed]
109. Jiang, N.M.; Cowan, M.; Moonah, S.N.; Petri, W.A., Jr. The Impact of Systemic Inflammation on Neurodevelopment. Trends Mol. Med. 2018, 24, 794–804. [CrossRef] [PubMed]
110. Peruzzotti-Jametti, L.; Pluchino, S. Targeting Mitochondrial Metabolism in Neuroinflammation: Towards a Therapy for Progressive Multiple Sclerosis. Trends Mol. Med. 2018, 24, 838–855. [CrossRef] [PubMed]
111. Deussing, J.M.; Arzt, E. P2X7 Receptor: A Potential Therapeutic Target for Depression? Trends Mol. Med. 2018, 24, 736–747. [CrossRef] [PubMed]
112. Zhuang, Z.Q.; Shen, L.L.; Li, W.W.; Fu, X.; Zeng, F.; Gui, L.; Lu, Y.; Cai, M.; Zhu, C.; Tan, Y.L.; et al. Gut Microbiota is Altered in Patients with Alzheimer’s Disease. J. Alzheimer’s Dis. JAD 2018, 63, 1337–1346. [CrossRef] [PubMed]
113. Wang, X.; Quinn, P.J. Endotoxins: Lipopolysaccharides of gram-negative bacteria. Sub-Cell. Biochem. 2010, 53, 3–25.
114. Yano, J.M.; Yu, K.; Donaldson, G.P.; Shastri, G.G.; Ann, P.; Ma, L.; Nagler, C.R.; Ismagilov, R.F.; Mazmanian, S.K.; Hsiao, E.Y. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 2015, 161, 264–276. [CrossRef] [PubMed]
115. Pistollato, F.; Sumalla Cano, S.; Elio, I.; Masias Vergara, M.; Giampieri, F.; Battino, M. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr. Rev. 2016, 74, 624–634. [CrossRef] [PubMed]
116. Calvo-Ochoa, E.; Arias, C. Cellular and metabolic alterations in the hippocampus caused by insulin signalling dysfunction and its association with cognitive impairment during aging and Alzheimer’s disease: Studies in animal models. Diabetes/Metab. Res. Rev. 2015, 31, 1–13. [CrossRef] [PubMed]
117. Honig, L.S.; Vellas, B.; Woodward, M.; Boada, M.; Bullock, R.; Borrie, M.; Hager, K.; Andreasen, N.; Scarpini, E.; Liu-Seifert, H.; et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease. N. Engl. J. Med. 2018, 378, 321–330. [CrossRef] [PubMed]
118. Lin, L.; Zheng, L.J.; Zhang, L.J. Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease. Mol. Neurobiol. 2018, 55, 8243–8250. [CrossRef] [PubMed]
119. Schwab, C.; Klegeris, A.; McGeer, P.L. Inflammation in transgenic mouse models of neurodegenerative disorders. Biochim. Biophys. Acta 2010, 1802, 889–902. [CrossRef] [PubMed]
120. Burns, J.M.; Honea, R.A.; Vidoni, E.D.; Hutfles, L.J.; Brooks, W.M.; Swerdlow, R.H. Insulin is differentially related to cognitive decline and atrophy in Alzheimer’s disease and aging. Biochim. Biophys Acta 2012, 1822, 333–339. [CrossRef] [PubMed]
121. Moore, A.H.; Wu, M.; Shaftel, S.S.; Graham, K.A.; O’Banion, M.K. Sustained expression of interleukin-1beta in mouse hippocampus impairs spatial memory. Neuroscience 2009, 164, 1484–1495. [CrossRef] [PubMed]
122. Wang, W.-Y.; Tan, M.-S.; Yu, J.-T.; Tan, L. Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Ann. Transl. Med. 2015, 3, 136. [PubMed]
123. Hansen, D.V.; Hanson, J.E.; Sheng, M. Microglia in Alzheimer’s disease. J. Cell Biol. 2018, 217, 459–472. [CrossRef] [PubMed]
124. Chen, P.L.; Wang, W.J.; Rao, Y.Q.; Li, J.; Cheng, M.J. Serum containing Gengnianchun formula suppresses amyloid β-induced inflammatory cytokines in BV-2 microglial cells by inhibiting the NF-κB and JNK signaling pathways. Mol. Med. Rep. 2018, 17, 5043–5048. [PubMed]
125. Trovato Salinaro, A.; Pennisi, M.; Di Paola, R.; Scuto, M.; Crupi, R.; Cambria, M.T.; Ontario, M.L.; Tomasello, M.; Uva, M.; Maiolino, L.; et al. Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer’s disease and Alzheimer-linked pathologies: Modulation by nutritional mushrooms. Immun. Ageing 2018, 15, 8. [CrossRef] [PubMed]
126. Schwartz, K.; Boles, B.R. Microbial amyloids—Functions and interactions within the host. Curr. Opin. Microbiol. 2013, 16, 93–99. [CrossRef] [PubMed]
127. Andersen, K.; Andersen, B.B.; Pakkenberg, B. Stereological quantification of the cerebellum in patients with Alzheimer’s disease. Neurobiol. Aging 2012, 33, 197.e11–197.e20. [CrossRef] [PubMed]
128. Sjobeck, M.; Englund, E. Alzheimer’s disease and the cerebellum: A morphologic study on neuronal and glial changes. Dement. Geriatr. Cognit. Disord. 2001, 12, 211–218. [CrossRef] [PubMed]
129. Mavroudis, I.A.; Fotiou, D.F.; Adipepe, L.F.; Manani, M.G.; Njau, S.D.; Psaroulis, D.; Costa, V.G.; Baloyannis, S.J. Morphological changes of the human purkinje cells and deposition of neuritic plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer’s disease. Am. J. Alzheimer’s Dis. Dement. 2010, 25, 585–591. [CrossRef] [PubMed]
130. Wegiel, J.; Wisniewski, H.M.; Dziewiatkowski, J.; Badmajew, E.; Tarnawski, M.; Reisberg, B.; Mlodzik, B.; De Leon, M.J.; Miller, D.C. Cerebellar atrophy in Alzheimer’s disease-clinicopathological correlations. Brain Res. 1999, 818, 41–50. [CrossRef]
131. Reddy, Y.M.; Singh, D.; Nagarajan, D.; Pillarisetti, J.; Biria, M.; Boolani, H.; Emert, M.; Chikkam, V.; Ryschon, K.; Vacek, J.; et al. Atrial fibrillation ablation in patients with gastroesophageal reflux disease or irritable bowel syndrome-the heart to gut connection! J. Interv. Card. Electrophysiol. 2013, 37, 259–265. [CrossRef] [PubMed]
132. Churchill, L.; Taishi, P.; Wang, M.; Brandt, J.; Cearley, C.; Rehman, A.; Krueger, J.M. Brain distribution of cytokine mRNA induced by systemic administration of interleukin-1beta or tumor necrosis factor alpha. Brain Res. 2006, 1120, 64–73. [CrossRef] [PubMed]
133. Foster, J.A.; Rinaman, L.; Cryan, J.F. Stress & the gut-brain axis: Regulation by the microbiome. Neurobiol. Stress 2017, 7, 124–136. [PubMed]
134. Zhang, R.; Miller, R.G.; Gascon, R.; Champion, S.; Katz, J.; Lancero, M.; Narvaez, A.; Honrada, R.; Ruvalcaba, D.; McGrath, M.S. Circulating endotoxin and systemic immune activation in sporadic Amyotrophic Lateral Sclerosis (sALS). J. Neuroimmunol. 2009, 206, 121–124. [CrossRef] [PubMed]
135. Ghosh, S.; Wu, M.D.; Shaftel, S.S.; Kyrkanides, S.; LaFerla, F.M.; Olschowka, J.A.; O’Banion, M.K. Sustained Interleukin-1β overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer’s mouse model. J. Neurosci. 2013, 33, 5053–5064. [CrossRef] [PubMed]
136. Terada, K.; Yamada, J.; Hayashi, Y.; Wu, Z.; Uchiyama, Y.; Peters, C.; Nakanishi, H. Involvement of cathepsin B in the processing and secretion of interleukin-1beta in chromogranin A-stimulated microglia. Glia 2010, 58, 114–124. [CrossRef] [PubMed]
137. Wu, Z.; Sun, L.; Hashioka, S.; Yu, S.; Schwab, C.; Okada, R.; Hayashi, Y.; McGeer, P.L.; Nakanishi, H. Differential pathways for interleukin-1beta production activated by chromogranin A and amyloid beta in microglia. Neurobiol. Aging 2013, 34, 2715–2725. [CrossRef] [PubMed]
138. Carvalho, B.M.; Guadagnini, D.; Tsukumo, D.M.L.; Schenka, A.A.; Latuf-Filho, P.; Vassallo, J.; Dias, J.C.; Kubota, L.T.; Carvalheira, J.B.C.; Saad, M.J.A. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia 2012, 55, 2823–2834. [CrossRef] [PubMed]
139. Tilvis, R.S.; Kahonen-Vare, M.H.; Jolkkonen, J.; Valvanne, J.; Pitkala, K.H.; Strandberg, T.E. Predictors of cognitive decline and mortality of aged people over a 10-year period. J. Gerontol. Ser. A Biol. Sci. Med. Sci. 2004, 59, 268–274. [CrossRef]
140. Cattaneo, A.; Cattane, N.; Galluzzi, S.; Provasi, S.; Lopizzo, N.; Festari, C.; Ferrari, C.; Guerra, U.P.; Paghera, B.; Muscio, C.; et al. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol. Aging 2017, 49, 60–68. [CrossRef] [PubMed]